An overview of current treatment strategies for β-thalassemia
Introduction: At least 40,000 people per year worldwide are born with β-thalassemia. Patients with β-thalassemia major are reliant on regular red blood cell transfusions for survival from a young age. For those with β-thalassemia intermedia or hemoglobin (Hb) E/β-thalassemia, symptoms range from mil...
Saved in:
Main Authors: | Maria Domenica Cappellini, Vip Viprakasit, Ali T. Taher |
---|---|
Other Authors: | Universita degli Studi di Milano |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/34772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies
by: Ali T. Taher, et al.
Published: (2022) -
Current and future treatment strategies for iron overload cardiomyopathy
by: Suwakon Wongjaikam, et al.
Published: (2018) -
A pharmacokinetic study of paracetamol in Thai β-thalassemia/HbE patients
by: Jeeranut Tankanitlert, et al.
Published: (2018) -
Kinetics of lipid radical formation in lipoproteins from β-thalassemia: Implication of cholesteryl esters and α-tocopherol
by: Lerksaipheng P.
Published: (2023) -
Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in β-Thalassemia/hemoglobin e patients
by: Supot Rodrat, et al.
Published: (2018)